Dr. O'Rourke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
145 Michigan St NE
Suite 3100
Grand Rapids, MI 49503Phone+1 616-954-9800Fax+1 616-954-2116
Education & Training
Madigan Army Medical CenterFellowship, Hematology and Medical Oncology, 1982 - 1985- Madigan Army Medical CenterResidency, Internal Medicine, 1976 - 1979
University of Michigan Medical SchoolClass of 1976
Certifications & Licensure
MI State Medical License 1995 - 2024
CO State Medical License 2013 - 2021
TX State Medical License 1986 - 1996- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Clinical Trials
- Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia. Start of enrollment: 2003 Jan 01
- Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant Start of enrollment: 2011 Apr 20
Publications & Presentations
PubMed
- 80 citationsIncreased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer.Polly E Kintzel, Sandra L. Chase, Lisa M Schultz, Timothy J O'Rourke
Pharmacotherapy. 2008-12-01 - 332 citationsFirst-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers.Branimir I. Sikic, Nehal Lakhani, Amita Patnaik, Sumit A. Shah, Sreenivasa R Chandana
Journal of Clinical Oncology. 2016-05-20 - 102 citationsHepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastomaQian Xie, Robert D. Bradley, Liang Kang, Julie Koeman, Maria Libera Ascierto
Proceedings of the National Academy of Sciences of the United States of America. 2012-01-10
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
